These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6300643)

  • 1. Potencies and channel properties induced by semirigid agonists at frog nicotinic acetylcholine receptors.
    Spivak CE; Waters J; Witkop B; Albuquerque EX
    Mol Pharmacol; 1983 Mar; 23(2):337-43. PubMed ID: 6300643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
    Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
    Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
    Spivak CE; Waters JA; Aronstam RS
    Mol Pharmacol; 1989 Jul; 36(1):177-84. PubMed ID: 2747625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1989 Sep; 250(3):842-52. PubMed ID: 2476549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
    Maleque MA; Souccar C; Cohen JB; Albuquerque EX
    Mol Pharmacol; 1982 Nov; 22(3):636-47. PubMed ID: 6296656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.
    Swanson KL; Allen CN; Aronstam RS; Rapoport H; Albuquerque EX
    Mol Pharmacol; 1986 Mar; 29(3):250-7. PubMed ID: 2419745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
    Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
    J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
    Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX
    Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
    Fitch RW; Kaneko Y; Klaperski P; Daly JW; Seitz G; Gündisch D
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1221-4. PubMed ID: 15686946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.
    Spivak CE; Maleque MA; Oliveira AC; Masukawa LM; Tokuyama T; Daly JW; Albuquerque EX
    Mol Pharmacol; 1982 Mar; 21(2):351-61. PubMed ID: 6285171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor.
    Costa AC; Swanson KL; Aracava Y; Aronstam RS; Albuquerque EX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):507-16. PubMed ID: 1690291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.
    Souccar C; Varanda WA; Daly JW; Albuquerque EX
    Mol Pharmacol; 1984 May; 25(3):384-94. PubMed ID: 6328264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of a semirigid agonist with Torpedo acetylcholine receptor.
    Kawai H; Cao L; Dunn SM; Dryden WF; Raftery MA
    Biochemistry; 2000 Apr; 39(14):3867-76. PubMed ID: 10747774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
    Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX
    Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel.
    Alkondon M; Rao KS; Albuquerque EX
    J Pharmacol Exp Ther; 1988 May; 245(2):543-56. PubMed ID: 2452874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, pharmacology, and molecular modeling studies of semirigid, nicotinic agonists.
    Waters JA; Spivak CE; Hermsmeier M; Yadav JS; Liang RF; Gund TM
    J Med Chem; 1988 Mar; 31(3):545-54. PubMed ID: 3258034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of analogs of histrionicotoxin with the acetylcholine receptor ionic channel complex and membrane excitability.
    Maleque MA; Brossi A; Witkop B; Godleski SA; Albuquerque EX
    J Pharmacol Exp Ther; 1984 Apr; 229(1):72-9. PubMed ID: 6323691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methylanatoxinol isomers: derivatives of the agonist (+)-anatoxin-a block the nicotinic acetylcholine receptor ion channel.
    Swanson KL; Aracava Y; Sardina FJ; Rapoport H; Aronstam RS; Albuquerque EX
    Mol Pharmacol; 1989 Feb; 35(2):223-31. PubMed ID: 2465486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    Khan IM; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.